PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
26-Apr-2024 Swedencare launches NaturVet by Swedencare: Bringing America’s leading pet brand to Europe Swedencare
26-Apr-2024 OncoZenge Releases Paper on BupiZenge™ Addressing Unmet Medical Needs OncoZenge
26-Apr-2024 Liebherr presents its innovative cooling solutions at Clinical Pharmacy Congress 2024 Liebherr
26-Apr-2024 Creative Enzymes Sets a New Standard with Recombinant Chlorophyllase Creative Enzymes
26-Apr-2024 Creative Enzymes Introduces Highly Efficient Recombinant Pseudomonas sp. Formaldehyde Dehydrogenase, C-His Tag for Enhanced Biocatalysis Creative Enzymes
25-Apr-2024 Lindus Health Debuts "All-in-One Diagnostics CRO" Solution for Diagnostic Clinical Trials Lindus Health
25-Apr-2024 BIAL appoints Pierluigi Antonelli as Non-Executive Board Member BIAL
25-Apr-2024 AAVantgarde announces updated NHP data from its Stargardt disease program in a poster presentation at the ARVO 2024 annual meeting AAVantgarde Bio
25-Apr-2024 V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors V-Bio Ventures
25-Apr-2024 Alfa Chemistry Intensifies Efforts on Transfer, Manufacturing and Modification of Graphene-Based Silicon-Carbon Composites Alfa Chemistry
25-Apr-2024 Three Featured Products Upgraded at Alfa Chemistry: Protection Reagents, Environmental Goods Standards, Porphyrins and Phthalocyanines Alfa Chemistry
24-Apr-2024 Kynos Therapeutics announces positive top line results from the first-in-human Phase I study of its KMO inhibitor, KNS366, demonstrating safety, tolerability and target engagement Kynos Therapeutics
24-Apr-2024 Ciliatech’s glaucoma implant CID receives favorable opinion on treating both open and narrow angle forms of disease  Andrew Lloyd Associates
23-Apr-2024 MPE launches the Myeloma and AL Amyloidosis European Clinical Trial Navigator Myeloma Patients Europe (MPE)
23-Apr-2024 CellProthera to share results from its Phase I/IIb study investigating the safety and efficacy of ProtheraCytes (CD34+ expanded stem cells) in acute myocardial infarction CellProthera
23-Apr-2024 Alfa Chemistry Acts as an Innovator and Leader in Surface Coating Technology Alfa Chemistry
23-Apr-2024 Alfa Chemistry's Premium Astaxanthin Ingredients: Taking a Step towards Improved Health Alfa Chemistry
22-Apr-2024 People living with pulmonary hypertension call for better psychological support in the absence of awareness of this severe disease Andrew Lloyd Associates
22-Apr-2024 BOC Sciences to Present Its Novel Solutions at the 2024 TIDES USA Conference BOC Sciences
22-Apr-2024 Lynred wins Sentinel-2 NG mission pre-development contract to design advanced multispectral infrared detector Andrew Lloyd Associates